About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Section on Developmental and Molecular Pharmacology
›
top-articles
Section on Developmental and Molecular Pharmacology
62
(top 2%)
papers
3.0K
(top 1%)
citations
32
(top 1%)
h
-index
54
(top 1%)
g
-index
63
all documents
3.1K
doc citations
593
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos
Nature
1993
268
2
Activity-dependent neuroprotective protein: a novel gene essential for brain formation
Developmental Brain Research
2003
224
3
A Glia-Derived Signal Regulating Neuronal Differentiation
Journal of Neuroscience
2000
200
4
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease1This manuscript is based on a poster presented at the Brain Research Interactive Symposium on “Neuropeptides at the Millennium”, Miami, October 1999.1
Brain Research
2000
147
5
Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome
Journal of Pharmacology and Experimental Therapeutics
2001
132
6
Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides
Journal of Pharmacology and Experimental Therapeutics
1998
100
7
Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes
Neuron Glia Biology
2004
94
8
VIP as a trophic factor in the CNS and cancer cells
Peptides
2003
93
9
Prevention of activity-dependent neuronal death: Vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I
Peptides
1996
82
10
Interleukin-1 alpha and vasoactive interstinal peptide: Enigmatic regulation of neuronal survival
International Journal of Developmental Neuroscience
1995
79
11
Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: Relation to ontogenic events
Journal of Comparative Neurology
1994
72
12
VIP and Peptides Related to Activity-Dependent Neurotrophic Factor Protect PC12 Cells Against Oxidative Stress
Journal of Molecular Neuroscience
2001
69
13
Activity-dependent neurotrophic factor (ADNF)
Journal of Molecular Neuroscience
1996
64
14
Neuropeptides as growth and differentiation factors in general and VIP in particular
Journal of Molecular Neuroscience
1993
63
15
A Novel Signaling Molecule for Neuropeptide Action: Activity-dependent Neuroprotective Protein
Annals of the New York Academy of Sciences
1999
60
16
CREB contributes to the increased neurite outgrowth of sensory neurons induced by vasoactive intestinal polypeptide and activity-dependent neurotrophic factor
Brain Research
2000
59
17
Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent.
Journal of Clinical Investigation
1996
59
18
Complex array of cytokines released by vasoactive intestinal peptide
Neuropeptides
2003
57
19
Sites of gene expression for vasoactive intestinal polypeptide throughout the brain of the chick (Gallus domesticus)
Neuropeptides
1997
53
20
Involvement of Pituitary Adenylate Cyclase‐Activating Polypeptide II Vasoactive Intestinal Peptide 2 Receptor in Mouse Neocortical Astrocytogenesis
Journal of Neurochemistry
1998
53
21
The identification of secreted heat shock 60 -like protein from rat glial cells and a human neuroblastoma cell line
Neuroscience Letters
1998
52
22
Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity
Developmental Brain Research
1997
50
23
Neurobehavioral Development of Neonatal Mice Following Blockade of VIP During the Early Embryonic Period
Peptides
1997
49
24
Maternal Regulation of Embryonic Growth: The Role of Vasoactive Intestinal Peptide*
Endocrinology
1999
49
25
A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism
Neuroscience Letters
1999
46
26
gp120 as an etiologic agent for NeuroAIDS: Neurotoxicity and model systems
Advances in Neuroimmunology
1994
44
27
VIP and d-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death
Brain Research
1999
43
28
Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus
Neuroscience Letters
2004
43
29
Identity of Neurotrophic Molecules Released from Astroglia by Vasoactive Intestinal Peptide
Annals of the New York Academy of Sciences
1997
42
30
VIP Neurotrophism in the Central Nervous System: Multiple Effectors and Identification of a Femtomolar-Acting Neuroprotective Peptide
Annals of the New York Academy of Sciences
1998
38
31
Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity
Neuropeptides
2002
38
32
Inhibition of human neuroblastoma growth by a specific VIP antagonist
Journal of Molecular Neuroscience
1994
37
33
NAP accelerates the performance of normal rats in the water maze
Journal of Molecular Neuroscience
2002
34
34
A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines
Cancer
2001
33
35
Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth
Neuroscience
1999
31
36
A Single Administration of the Peptide NAP Induces Long-Term Protective Changes Against the Consequences of Head Injury
Journal of Molecular Neuroscience
2002
31
37
IGF-I as a Mediator of VIP/Activity-Dependent Neurotrophic Factor-Stimulated Embryonic Growth
Endocrinology
2001
28
38
Vasoactive Intestinal Peptide: Link between Electrical Activity and Glia-mediated Neurotrophism
Annals of the New York Academy of Sciences
1999
27
39
Activity-dependent neurotrophic factor: a potent regulator of embryonic growth and development
Anatomy and Embryology
1999
27
40
A Vasoactive Intestinal Peptide Antagonist Inhibits the Growth of Glioblastoma Cells
Journal of Molecular Neuroscience
2001
26
41
A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms
Journal of Pharmacology and Experimental Therapeutics
1993
26
42
Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome
Experimental Neurology
2003
25
43
Neuropeptides and Neuronal Survival: Neuroprotective Strategy for Alzheimer's Disease
Annals of the New York Academy of Sciences
1997
22
44
A VIP hybrid antagonist: From developmental neurobiology to clinical applications
Cellular and Molecular Neurobiology
1995
21
45
VIP and PACAP 38 Modulate Ibotenate-Induced Neuronal Heterotopias in the Newborn Hamster Neocortex
Journal of Neuropathology and Experimental Neurology
2000
21
46
Vasoactive intestinal peptide regulation of nerve growth factor in the embryonic mouse
Peptides
2002
21
47
Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model
Regulatory Peptides
2002
21
48
Chemokines Released from Astroglia by Vasoactive Intestinal Peptide: Mechanism of Neuroprotection from HIV Envelope Protein Toxicity
Annals of the New York Academy of Sciences
2000
21
49
Vasoactive Intestinal Peptide Regulates Embryonic Growth Through the Action of Activity-dependent Neurotrophic Factor
Annals of the New York Academy of Sciences
1999
15
50
A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes
Life Sciences
2002
11
site/software ©
exaly
; All materials licenced under
CC by-SA
.